Drug lookup
Drug reference

Neomycin

Aminoglycoside · Antibacterial

Also known as Neomycin sulfate

AminoglycosideAntibacterialATC null
CDSCO approved
EXCRETION
not curated
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
There is a risk of auditory or vestibular nerve damage in the infant when aminoglycosides are used in the second and third trimesters of pregnancy.
FDA category + note
Top interactionssee all 12
  • AtracuriumSevereDatabaseDDInter
  • BacitracinSevereDatabaseDDInter
  • Botulinum Toxin Type ASevereDatabaseDDInter
  • Botulinum Toxin Type BSevereDatabaseDDInter

Mechanism

Neomycin is a bactericidal aminoglycoside active against some Gram-positive and many Gram-negative organisms. It reduces the bacterial population of the colon.

Indications

Infections of the skin or mucous membranesBowel sterilisation before surgeryHepatic comainfected wound (topical)ulcers (topical)burn (topical)external ear infections (topical)conjunctivitis (topical)preparation of bowel before surgery (oral)hepatic coma (oral, to suppress intestinal flora and diminish NH3 production)

Dosing

Adult
Bowel sterilisation before surgery: 1 g by mouth every 1 hour for 4 hours, then 1 g every 4 hours for 2–3 days. Hepatic coma: Up to 4 g daily by mouth in divided doses usually for 5–7 days.
Renal adjustment
Avoid due to risk of ototoxicity and nephrotoxicity.
Hepatic adjustment
Manufacturer advises caution (increased risk of ototoxicity and nephrotoxicity).
Max dose
Up to 4 g daily (for hepatic coma). Side effects increase after a cumulative dose of 100 g, which should only be exceeded in exceptional circumstances.

Pharmacokinetics

Bioavailability
Poorly absorbed after oral administration, but small amounts may be absorbed from the gut in patients with hepatic failure or inflammatory bowel disease.
Excretion
excreted unchanged by kidney (small absorbed amounts)

Contraindications

  • Intestinal obstruction
  • Myasthenia gravis
  • systemic use (too toxic)
  • impaired renal function
  • applied to serous cavities (risk of apnoea)
  • pregnancy
  • perforated eardrum (ear drops)
  • antidiarrhoeal formulations (banned in India)

Side effects

Common
DiarrhoeaGastrointestinal disordersNauseaOral disordersSuperinfectionVomitingMorphological abnormalities in intestinal mucosaSteatorrhoeaMalabsorption syndromerashes (topical)damaging effect on intestinal villimalabsorption syndrome (with diarrhoea and steatorrhoea)
Serious
  • Blood disorder
  • Confusion
  • Electrolyte imbalance
  • Haemolytic anaemia
  • Nephrotoxicity
  • Nystagmus
  • Ototoxicity
  • Paraesthesia
  • ototoxicity (mainly auditory)
  • kidney toxicity
  • apnoea (when applied to serous cavities)
  • superinfection by Candida

Pregnancy & lactation

Pregnancy

There is a risk of auditory or vestibular nerve damage in the infant when aminoglycosides are used in the second and third trimesters of pregnancy.

Drug interactions

Atracurium
Severe
Database

Clinical effect not specified

Source: DDInter

Bacitracin
Severe
Database

Clinical effect not specified

Source: DDInter

Botulinum Toxin Type A
Severe
Database

Clinical effect not specified

Source: DDInter

Botulinum Toxin Type B
Severe
Database

Clinical effect not specified

Source: DDInter

Bumetanide
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Capreomycin
Severe
Database

Clinical effect not specified

Source: DDInter

Cidofovir
Severe
Database

Clinical effect not specified

Source: DDInter

Cisatracurium
Severe
Database

Clinical effect not specified

Source: DDInter

Colistimethate
Severe
Database

Clinical effect not specified

Source: DDInter

Deferasirox
Severe
Database

Clinical effect not specified

Source: DDInter

Diatrizoate
Severe
Database

Clinical effect not specified

Source: DDInter

Etacrynic Acid
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Related guidelines

Other Aminoglycoside drugs

Ask House about Neomycin

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e, Katzung, BNF·Verified: 2026-05-10 · House clinical team